The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination
Authors:
- 3 April 2015
- journal article
- Published by Springer Nature in Leukemia
- Vol. 29 (11) , 2257-2260
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Histone H2B monoubiquitination: roles to play in human malignancyEndocrine-Related Cancer, 2014
- Loss of Asxl1 leads to myelodysplastic syndrome–like disease in miceBlood, 2014
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromesLeukemia, 2013
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsJournal of Clinical Investigation, 2013
- A common ancestry for BAP1 and Uch37 regulatorsBioinformatics, 2012
- Systematic and Quantitative Assessment of the Ubiquitin-Modified ProteomeMolecular Cell, 2011
- Prognostic Significance ofASXL1Mutations in Patients With Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressorThe EMBO Journal, 2010
- Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemiaBlood, 2010
- The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML networkNature, 2008